Risperidone in the treatment of autistic Thai children under 4 years of age.
Article
in English
| IMSEAR
| ID: sea-39711
ABSTRACT
The authors report five cases of very young children with autistic disorder, aged 2.1-3.7 years, treated with risperidone, as part of the comprehensive intervention. Treatment with risperidone 0.25-0.5 mg per day was associated with clinically meaningful decreases in problem behaviors including hyperactivity, irritability, and aggressiveness. There were also improvements in social relatedness and cooperation with developmental treatment. All of the children tolerated the medication well and experienced no untoward effects. The efficacy of risperidone in the treatment of very young children with autistic disorder reported here is consistent with findings in the limited number of cases previously reported in the literature. Controlled studies are needed to confirm the efficacy and safety of risperidone in the treatment of these children.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Autistic Disorder
/
Thailand
/
Severity of Illness Index
/
Humans
/
Male
/
Drug Administration Schedule
/
Child, Preschool
/
Sampling Studies
/
Follow-Up Studies
/
Treatment Outcome
Type of study:
Observational study
/
Prognostic study
Country/Region as subject:
Asia
Language:
English
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS